Company Novo Integrated Sciences, Inc.

Equities

NVOS

US67011T3005

Healthcare Facilities & Services

Market Closed - Nasdaq 01:30:00 26/06/2024 am IST 5-day change 1st Jan Change
0.7604 USD -0.80% Intraday chart for Novo Integrated Sciences, Inc. -7.14% -7.38%

Business Summary

Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

Number of employees: 179

Sales per Business

USD in Million2022Weight2023Weight Delta
Healthcare Services
65.4 %
8 71.5 % 8 65.4 % -2.04%
Product
34.5 %
3 28.4 % 4 34.5 % +29.93%
Corporate
0.1 %
0 0.0 % 0 0.1 % +204.94%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
12 100.0 % 13 100.0 % +7.11%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 18/18/18
Director of Finance/CFO 38 07/23/07
President 60 15/02
Chief Tech/Sci/R&D Officer - 01/21/01
Chief Tech/Sci/R&D Officer - 24/21/24
Chief Operating Officer 65 13/14/13
Treasurer 43 15/18/15

Members of the board

Members of the board TitleAgeSince
Director/Board Member 43 26/21/26
Chief Operating Officer 65 13/14/13
Director/Board Member 42 30/22/30
Chief Executive Officer 56 18/18/18
Director/Board Member 49 26/21/26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,054,523 17,755,470 ( 93.18 %) 0 93.18 %

Shareholders

NameEquities%Valuation
1,290,858 6.775 % 1 M $
BlackRock Institutional Trust Co. NA
1.532 %
291,921 1.532 % 306 517 $
Vanguard Global Advisers LLC
1.310 %
249,632 1.310 % 262 114 $
Geode Capital Management LLC
0.6714 %
127,929 0.6714 % 134 325 $
Virtu Financial LLC
0.3257 %
62,064 0.3257 % 65 167 $
XTX Topco Ltd.
0.2089 %
39,807 0.2089 % 41 797 $
33,280 0.1747 % 34 944 $
Northern Trust Investments, Inc.(Investment Management)
0.1464 %
27,905 0.1464 % 29 300 $
G1 Execution Services LLC
0.0937 %
17,853 0.0937 % 18 746 $
Tower Research Capital LLC
0.0580 %
11,058 0.0580 % 11 611 $

Company contact information

Novo Integrated Sciences, Inc.

11120 NE 2nd Street Suite 100

98004, Bellevue

+

http://novointegrated.com
address Novo Integrated Sciences, Inc.(NVOS)
  1. Stock Market
  2. Equities
  3. NVOS Stock
  4. Company Novo Integrated Sciences, Inc.